Biosimilars Report Issue 2, Clinician and Payer Perspectives
The second issue highlights the clincian and payer perspectives on the first biosimilar approved in the US, by Dr. Gary H. Lyman and Dr. Edward Pezalla.
![]() |
Podcast:
|
![]() |
Webinar:
|
![]() |
Request a Live MeetingWhich of the Following Best Describes Your Need for Education Related to Biosimilars? Over 85% of health care professionals would like to learn more about Biologics and Biosimilars. 96% of participants agreed that participating in a live meeting will improve their patients outcomes. Support available for Grand Rounds, Chapter Meetings, and other gatherings. |
![]() |
Survey Question:
|
|